Alignment Healthcare (NASDAQ:ALHC) Stock Price Target Lowered at Barclays

Alignment Healthcare (NASDAQ:ALHC) had its price objective cut by Barclays from $10.00 to $9.00 in a report published on Friday,Benzinga reports. They currently have an equal weight rating on the stock.

Several other brokerages have also recently commented on ALHC. Needham & Company LLC initiated coverage on Alignment Healthcare in a research report on Wednesday. They issued a “hold” rating for the company. Raymond James Financial reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Monday, October 12th. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. KeyCorp downgraded Alignment Healthcare from an “overweight” rating to a “sector weight” rating in a research note on Friday. Finally, UBS Group decreased their price objective on Alignment Healthcare from $22.00 to $9.00 and set a “neutral” rating for the company in a research report on Monday, October 12th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $14.27.

Alignment Healthcare Trading Down 9.8%

Alignment Healthcare stock opened at $7.27 on Friday. The company has a 50 day moving average price of $9.87 and a 200 day moving average price of $16.82. Alignment Healthcare has a 52 week low of $6.01 and a 52 week high of $25.12. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 55.93 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, October 29th. The company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04). Alignment Healthcare had a net margin of 0.59% and a return on equity of 13.32%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the previous year, the company posted $0.02 EPS. The company’s quarterly revenue was up 36.7% compared to the same quarter last year. Research analysts forecast that Alignment Healthcare will post 0.14 EPS for the current year.

Insider Buying and Selling at Alignment Healthcare

In other news, President Dawn Maroney sold 122,707 shares of the stock in a transaction on Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the transaction, the president owned 794,606 shares in the company, valued at $10,075,604.08. This represents a 13.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Joseph S. Konowiecki sold 23,511 shares of the firm’s stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $8.61, for a total transaction of $202,429.71. Following the transaction, the executive vice president owned 1,080,305 shares in the company, valued at $9,301,426.05. This represents a 2.13% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 1,061,967 shares of company stock valued at $13,642,490 over the last three months. 5.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in ALHC. Oregon Public Employees Retirement Fund lifted its stake in shares of Alignment Healthcare by 11.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 41,900 shares of the company’s stock worth $342,000 after buying an additional 4,400 shares during the last quarter. Vise Technologies Inc. grew its position in Alignment Healthcare by 31.2% in the 3rd quarter. Vise Technologies Inc. now owns 12,163 shares of the company’s stock worth $99,000 after purchasing an additional 2,894 shares during the last quarter. VestGen Advisors LLC acquired a new stake in Alignment Healthcare in the 3rd quarter worth $135,000. Park Avenue Securities LLC increased its holdings in shares of Alignment Healthcare by 37.2% during the 3rd quarter. Park Avenue Securities LLC now owns 59,635 shares of the company’s stock worth $487,000 after purchasing an additional 16,157 shares during the period. Finally, Sterling Capital Management LLC increased its holdings in shares of Alignment Healthcare by 839.9% during the 3rd quarter. Sterling Capital Management LLC now owns 6,739 shares of the company’s stock worth $55,000 after purchasing an additional 6,022 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

More Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment reported third-quarter revenue of $1.36 billion, up 36.7% year over year and above the $1.31 billion analyst estimate. Adjusted EPS of a $0.04 loss matched consensus. Alignment Healthcare Reports Third Quarter 2026 Results
• Positive Sentiment: Management is targeting at least 20% top-line growth in 2027, supporting the company’s longer-term expansion narrative. Alignment Targets 2027 Growth
• Neutral Sentiment: Barclays reduced its price target from $10 to $9 while maintaining an “equal weight” rating, implying potential upside but limited conviction. Barclays Rating
• Negative Sentiment: Alignment lowered its 2026 adjusted EBITDA outlook to at least $100 million, signaling weaker near-term profitability and helping offset the revenue beat. Alignment EBITDA Outlook
• Negative Sentiment: CMS reduced the 2027 Star Rating for Alignment’s California HMO contract H3815 from 4.0 to 3.5 stars. The contract serves approximately 75% of membership, raising concerns about bonus eligibility, enrollment and reimbursement economics. Alignment H3815 CMS Rating Concerns
• Negative Sentiment: KeyCorp downgraded ALHC from “overweight” to “sector weight,” while multiple law firms announced investigations into possible securities-law violations. These notices are allegations and do not establish wrongdoing, but they add reputational and legal overhang. Alignment Investigation Notice

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.